Efficacy and safety of a basal insulin+2-3 oral antihyperglycaemic drugs regimen versus a twice-daily premixed insulin plus metformin regimen after short-term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open-label, randomized controlled BEYOND-V trial

Pan, Q; Li, YJ; Wan, HL; Wang, JF; Xu, BH; Wang, GP; Jiang, CX; Liang, L; Feng, W; Liu, JC; Wang, T; Zhang, X; Cui, N; Mu, YM; Guo, LX

Guo, LX (通讯作者),Beijing Hosp, Natl Ctr Gerontol, Dept Endocrinol, 1 Dahua Rd, Beijing 100730, Peoples R China.;Mu, YM (通讯作者),Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, 28 Fuxing Rd, Beijing 100730, Peoples R China.

DIABETES OBESITY & METABOLISM, 2022; 24 (10): 1957

Abstract

Aim To compare the efficacy and safety of basal insulin glargine 100 units/ml (Gla) + 2-3 oral antihyperglycaemic drugs (OADs) with twice-daily premix......

Full Text Link